Showing results (1941-1950 of 3,662) with videos related to
Sort By:
Pageof 367
Breast (Edinburgh, Scotland)|November 28, 2016
Using ultrasound and palpation for predicting axillary lymph node status following neoadjuvant chemotherapy - Results from the multi-center SENTINA trialLukas Schwentner, Gisela Helms, Valentina Nekljudova, et al.Breast (Edinburgh, Scotland)|October 18, 2016
Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidenceOlugbenga Awolaran, Susan A Brooks, Verna LavenderBreast (Edinburgh, Scotland)|November 5, 2016
Lymphocyte-predominant triple-negative breast carcinomas in premenopausal patients: Lower expression of basal immunohistochemical markersSergio Mitsuo Masili-Oku, Bernardo Gomes Lacerda de Almeida, Carlos Eduardo Bacchi, et al.Breast (Edinburgh, Scotland)|November 5, 2016
Breast cancer diagnosis and mortality by tumor stage and migration background in a nationwide cohort study in SwedenGholamreza Abdoli, Matteo Bottai, Kerstin Sandelin, et al.Breast (Edinburgh, Scotland)|February 15, 2017
Outcomes and utilization of postmastectomy radiotherapy for T3N0 breast cancersSamual R Francis, Jonathan Frandsen, Kristine E Kokeny, et al.Breast (Edinburgh, Scotland)|February 9, 2017
Family history of cancer other than breast or ovarian cancer in first-degree relatives is associated with poor breast cancer prognosisJun-Long Song, Chuang Chen, Jing-Ping Yuan, et al.Breast (Edinburgh, Scotland)|February 4, 2017
Identification of high independent prognostic value of nanotechnology based circulating tumor cell enumeration in first-line chemotherapy for metastatic breast cancer patientsXiao-Ran Liu, Bin Shao, Jia-Xi Peng, et al.Breast (Edinburgh, Scotland)|February 7, 2017
Immunotherapy in breast cancer: An introductionMary L Disis, Sasha E StantonBreast (Edinburgh, Scotland)|January 21, 2017
Breast cancers detected in only one of two arms of a tomosynthesis (3D-mammography) population screening trial (STORM-2)Daniela Bernardi, Nehmat HoussamiBreast (Edinburgh, Scotland)|December 9, 2003
Growth factor receptor cross-talk with estrogen receptor as a mechanism for tamoxifen resistance in breast cancerC Kent Osborne, Rachel SchiffPageof 367